共 50 条
- [1] Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease MEDICINA CLINICA, 2024, 162 (09): : 409 - 416
- [4] Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (06):
- [5] Elevation of Liver Enzymes In Patients With Inflammatory Bowel Disease Treated With Upadacitinib Is Associated With Metabolic Risk Factors AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1081 - S1082
- [6] Cardiovascular Events and Risk Factors in Inflammatory Bowel Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S479 - S479
- [7] Factors associated with steatotic liver disease associated with metabolic dysfunction (MASLD) in patients with Inflammatory Bowel Disease (IBD) JOURNAL OF CROHNS & COLITIS, 2025, 19 : i871 - i871
- [10] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease Hepatology International, 2023, 17 : 626 - 635